Cargando…

The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A (11)C-MET PET Study

PURPOSE: We evaluated the relationship between isocitrate dehydrogenase 1 (IDH1) mutation status and metabolic imaging in patients with nonenhancing supratentorial diffuse gliomas using (11)C-methionine positron emission tomography ((11)C-MET PET). MATERIALS AND METHODS: Between June 2012 and Novemb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudulaiti, Nijiati, Zhang, Huiwei, Qiu, Tianming, Lu, Junfeng, Aibaidula, Abudumijiti, Zhang, Zhengwei, Guan, Yihui, Zhuang, Dongxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997723/ https://www.ncbi.nlm.nih.gov/pubmed/31889470 http://dx.doi.org/10.1177/1536012119894087

Ejemplares similares

Combination of Magnetic Resonance Spectroscopy and (11)C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma
por: Kudulaiti, Nijiati, et al.
Publicado: (2019)

A Nomogram Modeling (11)C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
por: Zhou, Weiyan, et al.
Publicado: (2020)

Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters
por: Pruis, Ilanah J, et al.
Publicado: (2022)

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
por: Liu, Feng-Min, et al.
Publicado: (2021)

MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma
por: Brighi, Caterina, et al.
Publicado: (2020)

Multimodal Imaging of Nonenhancing Glioblastoma Regions
por: John, Flóra, et al.
Publicado: (2019)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
por: Neumaier, Felix, et al.
Publicado: (2023)

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
por: Wollring, Michael M., et al.
Publicado: (2022)

Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report
por: Agopyan-Miu, Alexander H. C. W., et al.
Publicado: (2021)

A nomogram for individualized prediction of overall survival in patients with newly diagnosed glioblastoma: a real-world retrospective cohort study
por: Kudulaiti, Nijiati, et al.
Publicado: (2021)

Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas()
por: Luks, Tracy L., et al.
Publicado: (2018)

Spatial distribution of supratentorial diffuse gliomas: A retrospective study of 990 cases
por: Li, Gen, et al.
Publicado: (2023)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

The role of ventriculoperitoneal shunting in patients with supratentorial glioma
por: de la Fuente, Macarena I, et al.
Publicado: (2014)

Effect of Applying Leakage Correction on rCBV Measurement Derived From DSC-MRI in Enhancing and Nonenhancing Glioma
por: Arzanforoosh, Fatemeh, et al.
Publicado: (2021)

The role of allergic history in patients having supratentorial gliomas
por: Markova, Olga, et al.
Publicado: (2011)

A Retrospective Study on Spinal Dissemination of Supratentorial Glioma
por: Chen, Jianxin, et al.
Publicado: (2021)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
por: Tatekawa, Hiroyuki, et al.
Publicado: (2021)

Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors
por: Park, Yae Won, et al.
Publicado: (2019)

The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors
por: Cistaro, Angelina, et al.
Publicado: (2021)

Simultaneous static and time-resolved nonenhanced peripheral MR angiography
por: Koktzoglou, Ioannis, et al.
Publicado: (2013)

Cerebral Venous Sinus Thrombosis, a Nonenhanced CT Diagnosis?
por: Alsafi, Ali, et al.
Publicado: (2015)

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
por: Wang, Hao-Yuan, et al.
Publicado: (2016)

Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
por: Alzahrani, Awad, et al.
Publicado: (2023)

Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas
por: Miyake, Keisuke, et al.
Publicado: (2012)

Edge Constraint and Location Mapping for Liver Tumor Segmentation from Nonenhanced Images
por: Zhang, Jina, et al.
Publicado: (2022)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
por: Wei, Yanfei, et al.
Publicado: (2023)

Mini-temporal approach as an alternative to the classical pterional approach for resective temporal region surgeries
por: Kudulaiti, Nijiati, et al.
Publicado: (2022)

Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial IDH-Wildtype Glioblastomas in Adults
por: Moiraghi, Alessandro, et al.
Publicado: (2021)

Postoperative functional status in patients with supratentorial superficial low-grade glioma
por: Zhang, Ji, et al.
Publicado: (2017)

Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area [Letter]
por: Teixeira, Theo Moraes, et al.
Publicado: (2023)

Diagnostic Performance of Arterial Spin Labeling for Grading Nonenhancing Astrocytic Tumors
por: Khashbat, Delgerdalai, et al.
Publicado: (2017)

The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
por: Bowden, Stephen G, et al.
Publicado: (2020)

Pre-surgical connectome features predict IDH status in diffuse gliomas
por: Kesler, Shelli R., et al.
Publicado: (2019)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma()()
por: Sun, Chao, et al.
Publicado: (2020)

New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
por: Dimitrov, Lilia, et al.
Publicado: (2015)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION
por: Rahman, Masum, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3elvbieb1o2rkoc8rr6v5vdk2b